Lifeboat Foundation

Check out the on-demand sessions from the Low-Code/No-Code Summit to learn how to successfully innovate and achieve efficiency by upskilling and scaling citizen developers. Watch now.

When it comes to artificial intelligence (AI), the past year has been aspirational, but ultimately unsuccessful, says Athina Kanioura, who was named PepsiCo’s first chief strategy and transformation officer in September 2020. But she is optimistic about 2023.

“Think of how we started with the metaverse and the use of AI, suddenly it crumbled into pieces,” she told VentureBeat. “In AI, we tend to see what doesn’t work the first time, then we lose hope — but I think 2023 should be a year of hope and focus for AI.”

Online videos are a vast and untapped source of training data—and OpenAI says it has a new way to use it.

Dr. Campisi has been at the forefront of studying cellular senescence for decades, revealing the mysteries of these not-exactly-dead cells and their role in many diseases of aging. In this episode, she joins her colleague Gordon to discuss the characteristics and function of senescent cells, as well as promising interventions on the horizon. Judy also describes how to get lucky in science by being prepared to see the unexpected.

To be a sheep is to blindly follow the crowd. But is a sheep’s sheepiness really enough to make an entire flock walk around in a circle non-stop for days on end?

That’s a mystery the internet has pondered for about a week now and solving it has proved more difficult than you’d expect.

Continue reading “Eerie Video of Bizarre Sheep Phenomenon Has The World Running in Circles” »

A small human trial has tested CRISPR gene editing technology in the treatment of solid cancer tumors, including breast, colon, and lung cancer, with promising results.

DISCLOSURE: Longevity. Technology (a brand of First Longevity Limited) has been contracted by the company featured in this article to support its current funding round. Qualifying investors can find out more via the Longevity. Technology investment portal.

MedTech start-up Occuity has received a £343,000 Innovate UK Biomedical Catalyst (BMC) Award to fund the next stage of the development of its innovative AGE reader: an optical medical device that will enable non-invasive screening of diabetes in non-clinical settings such as opticians and pharmacies.

Biomedical Catalyst is the flagship Innovate UK grant funding competition for supporting UK health & life sciences SMEs. It supports the development of innovative solutions to health and healthcare challenges by providing financial support to accelerate the route to commercialisation.

Observations of Exoplanet WASP-39b show fingerprints of atoms and molecules, as well as signs of active chemistry and clouds.

WASP-39 b is a planet unlike any in our solar system – a Saturn.

Saturn is the sixth planet from the sun and has the second-largest mass in the Solar System. It has a much lower density than Earth but has a much greater volume. Saturn’s name comes from the Roman god of wealth and agriculture.

Summary: Study reveals a signaling pathway that controls the formation of synapses between pyramidal neurons and inhibitory neurons expressing the parvalbumin protein.

Source: King’s College London.

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has demonstrated that brain wiring requires the control of local protein synthesis at the level of specific synapse types.

A threat actor associated with cyberespionage operations since at least 2017 has been luring victims with fake VPN software for Android that is a trojanized version of legitimate software SoftVPN and OpenVPN.

Researchers say that the campaign was “highly targeted” and aimed at stealing contact and call data, device location, as well as messages from multiple apps.